Events
5th Antigen-Specific Immune Tolerance Drug Development Summit, virtual meeting
26-27 Januari 2021
Mangold Insight’s Investor Breakfast
29 September 2021
Aktiedagen Stockholm, virtual meeting
7 September 2021
MDA Insights in Research Investor Summit, virtual meeting
29-30 April 2021
4th Antigen-Specific Immune Tolerance Drug Development Summit, virtual meeting
26-28 January 2021
BioStock Live, Lund
8 September 2020
Stora Aktiedagen, Göteborg
4 November 2019
Sedermeradagen, Göteborg
4 October 2019
Småbolagsjakten Live, Stockholm
25 September 2019
Aktiekvällen, Göteborg
11 September 2019
World Orphan Drug Congress USA, Washington DC
10-12 April 2019
2nd Antigen-Specific Immune Tolerance Drug Development Summit, Boston
26-28 March 2019
Redeye Investor After Work, Göteborg
21 February 2019
1st Antigen-Specific Immune Tolerance Drug Development Europe, London
24-26 April 2018
BIO-Europe 2018 Partnering Conference, Copenhagen
5-7 November 2018
1st Antigen-Specific Immune Tolerance Drug Development Summit, Boston
24-26 April 2018
Aktiespararna Stockholm – Aktiekväll
19 February 2018
Connect2Capital Göteborg
7 February 2018
Aktiespararna Lerum – Årsmöte och Aktiekväll
25 January 2018
The business angel network IDA’s training day for members
2 June 2016
Charlotte Fribert, CEO, and Elisabet Litsmark, Chairman of the Board, will present Toleranzia and reasons why the company chose to be listed on AktieTorget at the business angel network IDA’s training day for members. IDA is a business angel network conducted within the framework of Connect West and investing in small entrepreneurial companies. The network has been around for about seven years and consists of some 30 women, several of whom have chosen to invest in Toleranzia.
Sedermeradagen Göteborg
1 June 2016
Charlotte Fribert, CEO, will present Toleranzia at Sedermeradagen Göteborg, taking place June 1 at Clarion Hotel Post in Gothenburg. Sedermeradagen Göteborg is arranged by Sedermera Fondkommission and is an investment day providing the opportunity to meet interesting companies within the micro- and small-cap segments.
World Orphan Drug Congress USA 2016
21 April 2016
Martina Verolin, Program Director, will present Toleranzia in the Pitch & Partner session at the World Orphan Drug Congress USA 2016, taking place at Washington Hilton, Washington, DC, USA, from 8 AM to 5 PM.
BIO-Europe Spring 2016
4-6 April 2016
Elisabet Litsmark Nordenstam, Chairman of the Board, will represent Toleranzia at the BIO-Europe Spring 2016 partnering conference, taking place at Kistamässan Convention Center in Kista (near Stockholm), Sweden.
GU Ventures’ 20th Anniversary Celebration
24 November 2015
The event will take place at the University of Gothenburg’s “Main Building” in Vasaparken, Gothenburg, Sweden, from noon to 3 p.m. Björn Löwenadler, CEO, and Charlotte Fribert, COO, will represent Toleranzia at the event. Registration is required no later than 17 November to ewa.ekman@ventures.gu.se.